Assessing and managing all aspects of migraine: Migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life

Mayo Clinic Proceedings

Volumn 84, Issue 5, 2009, Pages 422-435

  Buse, Dawn C ^a,b   Rupnow, Marcia F T ^c,d   Lipton, Richard B ^a,b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^d ETHICON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; BOTULINUM TOXIN; BUTORPHANOL; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROERGOTAMINE; ERGOTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PROPRANOLOL; RIBOFLAVIN; TIMOLOL; TOPIRAMATE; TRIPTAN DERIVATIVE; UBIDECARENONE; VALPROATE SEMISODIUM;

COMORBIDITY; DISABILITY; FATIGUE; FUNCTIONAL DISEASE; HEADACHE IMPACT TEST; HUMAN; INFECTION; MEMORY DISORDER; MIGRAINE; MOOD DISORDER; PARESTHESIA; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SHORT FORM 36; TASTE DISORDER;

EID: 66149160391     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.5.422     Document Type: Review

References (136)

1. World Health Organization. The World Health Report 2001: Mental Health: New Understanding, New Hope. http://www.who.int/whr/2001/en/index.html. Accessed January 12, 2009.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646-657. (Pubitemid 32777747)
3. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5(2):148-157. (Pubitemid 43107850)
4. Bigal ME, Lipton RB. When migraine progresses: transformed or chronic migraine. Expert Rev Neurother. 2006;6(3):297-306.
5. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 Dec;6(6):429-440. Epub 2005 Dec 15. (Pubitemid 43078769)
6. Clarke CE, MacMillan L, Sondhi S, Wells NE. Economic and social impact of migraine. QJM. 1996;89(1):77-84. (Pubitemid 26023967)
7. Dowson A, Jagger S. The UK Migraine Patient Survey: quality of life and treatment. Curr Med Res Opin. 1999;15(4):241-253. (Pubitemid 30008769)
8. Linde M, Dahlöf C. Attitudes and burden of disease among self-considered migraineurs: a nation-wide population-based survey in Sweden. Cephalalgia. 2004;24(6):455-465. (Pubitemid 38748027)
9. Dahlöf CG, Dimenäs E. Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia. 1995;15(1):31-36.
10. Dueland AN, Leira R, Cabelli ST. The impact of migraine on psychological well-being of young women and their communication with physicians about migraine: a multinational study. Curr Med Res Opin. 2005;21(8):1297-1305. (Pubitemid 41140734)
11. New survey reveals worrying between attacks can extend suffering for migraineurs [press release]. Titusville, NJ: Ortho-McNeil; June 8, 2006.
12. Holmes WF, MacGregor EA, Sawyer JP, Lipton RB. Information about migraine disability influences physicians' perceptions of illness severity and treatment needs. Headache. 2001;41(4):343-350. (Pubitemid 33728582)
13. Lipton RB, Hahn SR, Cady RK, et al. In-office discussions of migraine: results from the American Migraine Communication Study. J Gen Intern Med. 2008 Aug;23(8):1145-1151. Epub 2008 May 6.
14. Hahn SR, Lipton RB, Sheftell FD, Cady RK, Eagan CA, Simons SE, Nelson MR. Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communication Study (AMCS) Phase II. Curr Med Res Opin. 2008 Jun;24(6):1711-1718. Epub 2008 May 7.
15. Brandes JL. Global trends in migraine care: results from the MAZE survey. CNS Drugs. 2002;16(suppl 1):13-18.
16. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Interview Survey. Headache. 1993;33(1):29-35. (Pubitemid 23057823)
17. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290(18):2443-2454. (Pubitemid 37430544)
18. Hawkins K, Wang S, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49(4):368-374. (Pubitemid 46624354)
19. Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia. 2003;23(6):429-440. (Pubitemid 36776059)
20. Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy M. The patients' perceptions of migraine and chronic daily headache: a qualitative study. J Headache Pain. 2005 Feb;6(1):40-47. Epub 2005 Jan 25. (Pubitemid 40277270)
21. Peres MF, Mercante JP, Guendler VZ, et al. Cephalalgiaphobia: a possible specific phobia of illness. J Headache Pain. 2007 Feb;8(1):56-59. Epub 2007 Feb 19.
22. Cupini LM, Calabresi P. Medication-overuse headache: pathophysiological insights. J Headache Pain. 2005;6(4):199-202. (Pubitemid 41349302)
23. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3(8):475-483. (Pubitemid 38903098)
24. Silberstein SD, Olesen J, Bousser M-G, et al; International Headache Society. The International Classification of Headache Disorders, 2nd Edition (ICHD-II): revision of criteria for 8.2 medication-overuse headache [published correction appears in Cephalalgia. 2006;26(3):360]. Cephalalgia. 2005;25(6):460-465.
25. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19(2):107-114. (Pubitemid 29170106)
26. Ware JE Jr, Bjorner JB, Kosinski M. Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales. Med Care. 2000;38(9)(suppl):II73- II82.
27. Dowson AJ. Assessing the impact of migraine. Curr Med Res Opin. 2001;17(4):298-309. (Pubitemid 34150439)
28. Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology. 2005;65(12)(suppl 4):S50-S58. (Pubitemid 43755491)
29. Headache Impact Test-6 Web site. http://www.headachetest.com/HIT6/PDFS/ English.pdf. Accessed January 13, 2009.
30. Pryse-Phillips W. Evaluating migraine disability: the headache impact test instrument in context. Can J Neurol Sci. 2002;29(suppl 2):S11-S15.
31. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford Hospital Headache Disability Inventory (HDI). Neurology. 1994;44(5):837-842. (Pubitemid 24158796)
32. Stewart WF, Lipton RB, Simon D, Von Korff M, Liberman J. Reliability of an illness severity measure for headache in a population sample of migraine sufferers. Cephalalgia. 1998;18(1):44-51. (Pubitemid 28096518)
33. Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41(9):854-861. (Pubitemid 33043148)
34. World Health Organization. International Classification of Functioning, Disability and Health. Agenda item 13.9, 54th World Health Assembly, 9th plenary meeting, May 22, 2001. http://www.who.int/classification/icf/site/whares/wha- en.pdf. Accessed November 2007.
35. Buse DC, Bigal MB, Rupnow M, Reed M, Serrano D, Lipton RB. Development and validation of the Migraine Interictal Burden Scale (MIBS): a self-administered instrument for measuring the burden of migraine between attacks [abstract S05.003]. Neurology. 2007;68(suppl 1):A89.
36. Buse D, Bigal M, Rupnow M, et al. The Migraine Interictal Burden Scale (MIBS): results of a population-based validation study [abstract F64]. Headache. 2007;47(5):778.
37. Solomon GD, Skobieranda FG, Gragg LA. Quality of life and well-being of headache patients: measurement by the Medical Outcomes Study instrument. Headache. 1993;33(7):351-358. (Pubitemid 23221822)
38. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30(6):473-483.
39. Osterhaus JT, Townsend RJ, Gandek B, Ware JE Jr. Measuring the functional status and well-being of patients with migraine headache. Headache. 1994;34(6):337-343. (Pubitemid 24217820)
40. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D'Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci. 2004;25(suppl 3):S105-S107. (Pubitemid 41461969)
41. Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache. 2000;40(3):204-215. (Pubitemid 30169885)
42. Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res. 1993;27(2):211-221. (Pubitemid 23234204)
43. Jette N, Patten S, Williams J, Becker W, Wiebe S. Comorbidity of migraine and psychiatric disorders: a national population-based study. Headache. 2008 Apr;48(4):501-516. Epub 2007 Dec 7.
44. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Migraine headache disability and health-related quality-of-life: a population- based case-control study from England. Cephalalgia. 2003;23(6):441-450. (Pubitemid 36776060)
45. Dueland AN, Leira R, Burke TA, Hillyer EV, Bolge S. The impact of migraine on work, family, and leisure among young women: a multinational study. Curr Med Res Opin. 2004;20(10):1595-1604. (Pubitemid 39457547)
46. Lantéri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain. 2005 Dec;118(3):319-326. Epub 2005 Nov 14. (Pubitemid 41752989)
47. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. (Pubitemid 126433231)
48. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalagia.2004;24(suppl 1):1-160.
49. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. (Pubitemid 32823891)
50. Spitzer RL, Kroenke K, Williams JB; Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737-1744. (Pubitemid 29533604)
51. Lipton RB, Kolodner K, Bigal M, et al. Validity and reliability of the Migraine Treatment Optimization Questionnaire (M-TOQ) in the treatment of migraine [abstract P06.033]. Neurology. 2007;68(suppl 1):A263.
52. Lipton R, Kolodner K, Bigal M, et al. Validity and reliability of the Migraine-Treatment Optimization Questionnaire. Cephalalgia. 2009 Feb 23 [Epub ahead of print].
53. Stewart WF, Ricci JA, Leotta C, Chee E. Validation of the work and health interview. Pharmacoeconomics. 2004;22(17):1127-1140. (Pubitemid 39665343)
54. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Rev. Washington, DC: American Psychiatric Press; 2000.
55. Simpson M, Buckman R, Stewart M, et al. Doctor-patient communication: the Toronto consensus statement. BMJ. 1991;303(6814):1385-1387.
56. Lansky D. Measuring what matters to the public. Health Aff (Millwood). 1998;17(4):40-41. (Pubitemid 128465129)
57. The Medical School Objectives Writing Group. Learning objectives for medical student education: guidelines for medical schools: report I of the Medical School Objectives Project. Acad Med. 1999;74(1):13-18.
58. Makoul G. Essential elements of communication in medical encounters: the Kalamazoo consensus statement. Acad Med. 2001;76(4):390-393. (Pubitemid 32298942)
59. Hulsman RL, Ros WJ, Winnubst JA, Bensing JM. Teaching clinically experienced physicians communication skills: a review of evaluation studies. Med Educ. 1999;33(9):655-668. (Pubitemid 29425504)
60. Hall JA, Irish JT, Roter DL, Ehrlich CM, Miller LH. Satisfaction, gender, and communication in medical visits. Med Care. 1994;32(12):1216-1231.
61. Frederikson LG. Exploring information-exchange in consultation: the patients' view of performance and outcomes. Patient Educ Couns. 1995;25(3):237-246.
62. Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care. 1988;26(7):657-675.
63. Cox K, Stevenson F, Britten N, Dundar Y. A systematic review of two-way communication between patients and healthcare professionals about medicines. National Prescribing Centre Web site. http://www.npc.co.uk/med-partnership/ resource/major-reviews/systematic-review.html. Published May 2004. Accessed January 13, 2009.
64. Stewart M, Meredith L, Brown JB, Galajda J. The influence of older patient-physician communication on health and health-related outcomes. Clin Geriatr Med. 2000;16(1):25-36. (Pubitemid 30090331)
65. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152(9):1423-1433.
66. Cole SA. Reducing malpractice risk through more effective communication. Am J Manag Care. 1997;3(4):649-653. (Pubitemid 127528790)
67. Bensing JM, Roter DL, Hulsman RL. Communication patterns of primary care physicians in the United States and the Netherlands. J Gen Intern Med. 2003;18(5):335-342. (Pubitemid 36752685)
68. Roter DL, Hall JA, Kern DE, Barker LR, Cole KA, Roca RP. Improving physicians' interviewing skills and reducing patients' emotional distress: a randomized clinical trial. Arch Intern Med. 1995;155(17):1877-1884.
69. Mueller PS, Barrier PA, Call TG, et al. Views of new internal medicine faculty of their preparedness and competence in physician-patient communication. BMC Med Educ. 2006;6(May 26):30.
70. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor- Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or healthcare outcomes? JAMA. 1999;282(9):867-874. (Pubitemid 29408939)
71. Fellowes D, Wilkinson S, Moore P. Communication skills training for healthcare professionals working with cancer patients, their families and/or carers. Cochrane Database Syst Rev. 2004;2:CD003751.
72. Roter DL, Hall JA, eds. Improving talk through interventions. In: Doctors Talking With Patients/Patients Talking With Doctors: Improving Communication in Medical Visits. 2nd ed. Westport, CT: Praeger; 2006:163-181.
73. Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K. Approaching difficult communication tasks in oncology. CA Cancer J Clin. 2005;55(3):164-177. (Pubitemid 40826486)
74. Boyle D, Dwinnell B, Platt F. Invite, listen, and summarize: a patient-centered communication technique. Acad Med. 2005;80(1):29-32. (Pubitemid 40075732)
75. Martin LR, Jahng KH, Golin CE, DiMatteo MR. Physician facilitation of patient involvement in care: correspondence between patient and observer reports. Behav Med. 2003;28(4):159-164. (Pubitemid 37474273)
76. Abdel-Tawab N, Roter D. The relevance of client-centered communication to family planning settings in developing countries: lessons from the Egyptian experience. Soc Sci Med. 2002;54(9):1357-1368. (Pubitemid 34240049)
77. Ishikawa H, Takayama T, Yamazaki Y, Deki Y, Katsumata N. Physician- patient communication and patient satisfaction in Japanese cancer consultations. Soc Sci Med. 2002;55(2):301-311. (Pubitemid 34621446)
78. Roter DL, Larson S, Shinitzky H, et al. Use of an innovative video feedback technique to enhance communication skills training [published correction appears in Med Educ. 2005;39(6):645]. Med Educ. 2004;38(2):145-157. (Pubitemid 40776354)
79. Hahn SR. Communication in the care of the headache patient. In: Silberstein SD, Lipton RB, Dodick DW, eds. Wolff's Headache and Other Head Pain. 8th ed. New York, NY: Oxford University Press; 2008:805-824.
80. Lake AE III, Rains JC, Penzien DB, Lipchik GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache. 2005;45(5):493-506. (Pubitemid 40847172)
81. McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain. 2004;111(1-2):77-83. (Pubitemid 39141009)
82. DiMatteo MR, Hays RD, Prince LM. Relationship of physicians' non-verbal communication skill to patient satisfaction, appointment noncompliance, and physician workload. Health Psychol. 1986;5(6):581-594.
83. Buller MK, Buller DB. Physicians' communication style and patient satisfaction. J Health Soc Behav. 1987;28(4):375-388. (Pubitemid 18017784)
84. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284-1292.
85. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. (Pubitemid 43765180)
86. Lipton RB, Silberstein SD. The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology. 2001;56(6, suppl 1):S35-S42. (Pubitemid 32240084)
87. Buse DC, Lipton RB. Facilitating communication with patients for improved migraine outcomes. Curr Pain Headache Rep. 2008;12(3):230-236.
88. Rains JC, Penzien DB, Lipchik GL. Behavioral facilitation of medical treatment for headache, Part II: theoretical models and behavioral strategies for improving adherence. Headache. 2006;46(9):1395-1403. (Pubitemid 44556430)
89. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York, NY: Guilford Press; 2002.
90. Silberstein SD; US Headache Consortium. Practice parameter: evidence-based guidelines for migraine headache (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-762. http://www.neurology.org/cgi/reprint/55/ 6/754.pdf. Accessed January 13, 2009.
91. Dowson AJ, Lipscombe S, Sender J, Rees T, Watson D; MIPCA Migraine Guidelines Development Group; Migraine In Primary Care Advisors. New guidelines for the management of migraine in primary care. Curr Med Res Opin. 2002;18(7):414-439. (Pubitemid 35448539)
92. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med. 2002;346(4):257-270.
93. Bigal ME, Lipton RB. Acute treatment of migraine headache. Curr Treat Options Neurol. 2003;5(6):423-430.
94. Bigal ME, Lipton RB. The preventive treatment of migraine. Neurologist. 2006;12(4):204-213. (Pubitemid 44134046)
95. Kaniecki, R. Neuromodulators for migraine prevention. Headache. 2008 Apr;48(4):586-600. Epub 2008 Jan 18.
96. Lipton RB. Disability assessment as a basis for stratified care. Cephalalgia. 1998;18(suppl 22):40-43.
97. Lake AE III. Medication overuse headache: biobehavioral issues and solutions. Headache. 2006;46(suppl 3):S88-S97. (Pubitemid 44521780)
98. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM; US Headache Consortium. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. http://www.aan.com/professionals/practice/pdfs/gl0090.pdf. Accessed January 13, 2009.
99. Ramadan NM. Migraine headache prophylaxis: current options and advances on the horizon. Curr Neurol Neurosci Rep. 2006;6(2):95-99.
100. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; American Migraine Prevalence and Prevention (AMPP) Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349. (Pubitemid 46184209)
101. Lipton R, Serrano D, Buse D, Rupnow M, Reed M, Bigal M. The Migraine Prevention Questionnaire (MPQ): development and validation [abstract F48]. Headache. 2007;47(5):770-771.
102. Blocadren (timolol meleate) [package insert]. Whitehouse Station, NJ: Merck & Co; 2002.
103. Depakote ER (divalproex sodium extended-release) [package insert]. North Chicago, IL: Abbot Laboratories; 2006.
104. Topamax (topiramate) [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceutical; 2004.
105. Inderal LA (propranolol hydrocholoride) long-acting Capsules. [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals; 2007.
106. Snow V, Weiss K, Wall EM, Mottur-Pilson C; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137(10):840-849.
107. Modi S, Lowder DM. Medications for migraine prophylaxis [published correction appears in Am Fam Physician. 2006;74(10):1685]. Am Fam Physician. 2006;73(1):72-78.
108. Mendizabal JE. Extended-release divalproex sodium improves the quality of life of adolescent migraineurs [letter]. Headache. 2002;42(4):327-328. (Pubitemid 34568915)
109. Garcia-Monco JC, Foncea N, Bilbao A, Ruiz de Velasco I, Gomez- Beldarrain M. Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients. Cephalalgia 2007 Aug;27(8):920-928. Epub 2007 Jul 23. (Pubitemid 47125353)
110. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965-973. (Pubitemid 38543754)
111. Diener HC, Tfelt-Hansen P, Dahlöf C, et al; MIGR-003 Study Group. Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control. J Neurol. 2004;251(8):943-950. (Pubitemid 39119312)
112. Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490-495. (Pubitemid 38923736)
113. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study [published correction appears in Cephalalgia. 2007;27(8):962]. Cephalalgia. 2007Jul;27(7):814-823. Epub 2007 Apr 18. (Pubitemid 47125364)
114. Silberstein SD, Lipton RB, Dodick DW, et al; Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007;47(2):170-180. (Pubitemid 46246319)
115. Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC. Topiramate improves health-related quality of life when used to prevent migraine. Headache. 2005:45(8):1023-1030.
116. Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S. The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin. 2006;22(6):1021-1029. (Pubitemid 44000723)
117. Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ. Assessing the ability of topiramate to improve the daily activities of patients with migraine. Mayo Clin Proc. 2006;81(10):1311-1319. (Pubitemid 44484969)
118. Lofland JH, Gagne JJ, Pizzi LT, Rupnow M, Silberstein SD. Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials. J Occup Environ Med. 2007:49(3):252-257. (Pubitemid 46411481)
119. Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes. 2007;5(Oct 4):56. (Pubitemid 350177225)
120. Dodick DW, Silberstein S, Saper J, et al. The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache. 2007;47(10):1398-1408. (Pubitemid 350209536)
121. Campbell JK, Penzien DB, Wall EM; US Headache Consortium. Evidence-based guidelines for migraine headache: behavioral and physical treatments. American Academy of Neurology. 2000:1-29. http://www.aan.com/professionals/practice/pdfs/ gl0089.pdf. Accessed January 13, 2009.
122. Goslin RE, Gray RN, McCrory DC, et al. Behavioral and physical treatments for migraine headache. Technical review 2.2 February 1999. Prepared for the Agency for Healthcare Policy and Research under Contract No. 290-94-2025. http://www.clinpol.mc.duke.edu. Accessed November 2007.
123. Scharff L, Marcus DA, Turk DC. Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache. 1996;36(5):285-290. (Pubitemid 26162550)
124. Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: three decades of experience and empiricism. Applied Psychophysiol Biofeedback. 2002;27(2):163-181.
125. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006;46(9):1334-1343. (Pubitemid 44556426)
126. Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2008;48(1):16-25.
127. Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache. 2002;42:845-854. (Pubitemid 35285373)
128. Harpole LH, Samsa GP, Jurgelski AE, Shipley JL, Bernstein A, Matchar DB. Headache management program improves outcome for chronic headache. Headache. 2003;43(7):715-724. (Pubitemid 36993008)
129. Blumenfeld A, Tischio M. Center of excellence for headache care: group model at Kaiser Permanente. Headache. 2003;43(5):431-440. (Pubitemid 36554656)
130. Buse DC, Andrasik F. Behavioral medicine for migraine. Neurol Clin. 2009;27(2):445-465.
131. Rains JC, Pension DB, McCrory DC, Gray RN. Behavioral headache treatment: history, review of the empirical literature, and methodological critique. Headache. 2005;45(suppl 2):S92-S109. (Pubitemid 40846456)
132. Beck AT, Rush AJ, Shaw BF, Emery G, eds. Cognitive techniques: In Cognitive Therapy of Depression. New York, NY: Guilford Press; 1979:142-166.
133. Schwartz MS, Andrasik F, eds. Biofeedback: A Practitioner's Guide. 3rd ed. New York, NY: Guilford Press; 2003.
134. Penzien DB, Holroyd KA. Psychosocial interventions in the management of recurrent headache disorders, II: description of treatment techniques. Behav Med. 1994;20(2):64-73. (Pubitemid 24308182)
135. Hammond DC, ed. Handbook of Hypnotic Suggestions and Metaphors. New York, NY: Norton and Company; 1990.
136. Rothrock JF, Parada VA, Sims C, Key K, Walters NS, Zweifler RM. The impact of intensive patient education on clinical outcome in a clinic-based migraine population [published correction appears in Headache. 2006;46(7):1227]. Headache. 2006;46(5):726-731.